Pityriasis rubra pilaris successfully treated with adalimumab

Clinical and Experimental Dermatology

Volumn 35, Issue 7, 2010, Pages 792-793

  Schreml, S ^a   Zeller, V ^a   Babilas, P ^a   Karrer, S ^a   Landthaler, M ^a   Szeimies, R M ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETRETIN; METHOTREXATE; PSORALEN; STEROID; DERMATOLOGICAL AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANAMNESIS; CASE REPORT; DRUG WITHDRAWAL; HAIR DISEASE; HAIR EFFLUVIUM; HUMAN; LETTER; MALE; NAIL DISEASE; NAIL LOSS; PHOTOTHERAPY; PHYSICAL EXAMINATION; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION; ANTAGONISTS AND INHIBITORS;

AGED; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; MALE; PITYRIASIS RUBRA PILARIS; TUMOR NECROSIS FACTOR-ALPHA; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77956700503     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03806.x     Document Type: Letter

References (6)

1. Menter A, Tyring SK, Gordon K et al. Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial. J Am Acad Dermatol 2008 58: 106 115.
2. Walling HW, Swick BL. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch Dermatol 2009 145: 99 101.
3. Klein A, Szeimies RM, Landthaler M, Karrer S. Exacerbation of pityriasis rubra pilaris under efalizumab therapy. Dermatology 2007 215: 72 5.
4. Liao WC, Mutasim DF. Infliximab for the treatment of adult-onset pityriasis rubra pilaris. Arch Dermatol 2005 141: 423 425.
5. Seckin D, Tula E, Ergun T. Successful use of etanercept in type I pityriasis rubra pilaris. Br J Dermatol 2008 158: 642 644.
6. Burmester GR, Mease PJ, Dijkmans BA et al. Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis 2009 68: 1863 1869.